Literature DB >> 26698261

Construction of tissue engineered skin with human amniotic mesenchymal stem cells and human amniotic epithelial cells.

S-C Yu1, Y-Y Xu, Y Li, B Xu, Q Sun, F Li, X-G Zhang.   

Abstract

OBJECTIVE: To establish a new model for construction of tissue engineered skin with human amniotic mesenchymal stem cells (hAMSCs) and human amniotic epithelial cells (hAECs).
MATERIALS AND METHODS: hAMSCs and hAECs were isolated from amniotic membrane. The morphology and phenotype of hAMSCs and hAECs were confirmed by microscope and flow cytometry, respectively. Then, we performed RT-PCR and immunofluorescence staining to assess the expression of stem cells and keratinocyte markers. Moreover, cell co-culture was performed to observe the growth and phenotype characteristics of hAMSCs and hAECs in vitro. In addition, tissue engineered skin with hAMSCs and hAECs was constructed and assessed with histological methods.
RESULTS: hAMSCs and hAECs were successfully isolated, exhibiting fibroblast-like morphous and cobblestone-shape epithelial morphous, respectively. The surface biomarker analysis showed that hAMSCs and hAECs were both positive for CD73, CD90 and CD105, and negative for CD34 and HLA-DR. The RT-PCR showed that hAMSCs expressed stem cell marker Nanog and c-MYC, and keratinocyte marker K19, β1 integrin and K8, whereas hAECs expressed stem cell marker KLF4 and c-MYC, and keratinocyte marker K19, β1 integrin, K5 and K8. The expression of keratinocyte proliferation antigen K14 was also found on hAECs. Furthermore, we found co-culture has no impact on the phenotype of hAMSCs and hAECs, but increased the proliferation activity of hAECs and decreased the proliferation activity of hAMSCs. Finally, the histological analysis showed that the tissue engineered skin exhibited similar structure as normal skin.
CONCLUSIONS: Tissue engineered skin with hAMSCs and hAECs was successfully constructed and shown a similar feature as a skin equivalent. The tissue engineered skin might have good application prospects in regenerative medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26698261

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

1.  Hyaluronic acid (HA)-based hydrogels for full-thickness wound repairing and skin regeneration.

Authors:  Lei Hong; Meiting Shen; Jiaxi Fang; Yezhao Wang; Zhiyuan Bao; Shizhong Bu; Yabin Zhu
Journal:  J Mater Sci Mater Med       Date:  2018-09-08       Impact factor: 3.896

2.  The differentiation effect of bone morphogenetic protein (BMP) on human amniotic epithelial stem cells to express ectodermal lineage markers.

Authors:  Felor Biniazan; Asma Manzari-Tavakoli; Fahimeh Safaeinejad; Ali Moghimi; Farzad Rajaei; Hassan Niknejad
Journal:  Cell Tissue Res       Date:  2020-09-22       Impact factor: 5.249

3.  Differentiation of UC-MSCs into hepatocyte-like cells in partially hepatectomized model rats.

Authors:  Zheng Chen; Qiaoting Kuang; Xue-Jun Lao; Jie Yang; Weidong Huang; Dong Zhou
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

Review 4.  Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells.

Authors:  Quan-Wen Liu; Qi-Ming Huang; Han-You Wu; Guo-Si-Lang Zuo; Hao-Cheng Gu; Ke-Yu Deng; Hong-Bo Xin
Journal:  Int J Mol Sci       Date:  2021-01-19       Impact factor: 5.923

5.  Transcriptomic and Functional Evidence Show Similarities between Human Amniotic Epithelial Stem Cells and Keratinocytes.

Authors:  Li-Ping Liu; Dong-Xu Zheng; Zheng-Fang Xu; Hu-Cheng Zhou; Yun-Cong Wang; Hang Zhou; Jian-Yun Ge; Daisuke Sako; Mi Li; Kazunori Akimoto; Yu-Mei Li; Yun-Wen Zheng
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

6.  Human amniotic mesenchymal stem cells combined with PPCNg facilitate injured endometrial regeneration.

Authors:  Jiayue Huang; Wenwen Zhang; Jie Yu; Yating Gou; Nizhou Liu; Tingting Wang; Congcong Sun; Benyuan Wu; Changjiang Li; Xinpei Chen; Yanhua Mao; Yingfeng Zhang; Jia Wang
Journal:  Stem Cell Res Ther       Date:  2022-01-12       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.